Publications by authors named "David M Colcher"

Claim this Profile
D
Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors.
Eric Aniogo, Lindsay Williams, Teresa Hong, Patty Wong, Susanta K Hui, David M Colcher

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Matthew C Hernandez, Paul Yazaki, Joanne E Mortimer, Dave Yamauchi, Erasmus Poku, David M Colcher

Nucl Med Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-In-Human Pilot PET Immunoimaging Study of Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.
Jeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, Jennifer Simpson, Paul H Frankel, David M Colcher

Cancer Biother Radiopharm· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.
Joanne E Mortimer, James R Bading, Paul H Frankel, Mary I Carroll, Yuan Yuan, David M Colcher

J Nucl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Template-Catalyzed, Disulfide Conjugation of Monoclonal Antibodies Using a Natural Amino Acid Tag.
Jeremy D King, Yuelong Ma, Yi-Chiu Kuo, Krzysztof P Bzymek, Leah H Goodstein, David M Colcher

Bioconjug Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Uptake of Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.
Joanne E Mortimer, James R Bading, Jinha M Park, Paul H Frankel, Mary I Carroll, David M Colcher

J Nucl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic PET Imaging of Mammary Microcalcifications Using Cu-DOTA-Alendronate in a Rat Model of Breast Cancer.
Bradley J Ahrens, Lin Li, Alexandra K Ciminera, Junie Chea, Erasmus Poku, David M Colcher

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.
Joanne E Mortimer, James R Bading, David M Colcher, Peter S Conti, Paul H Frankel

J Nucl Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination and control of volatilized 131I released in the preparation of 131I tositumomab dosages for radioimmunotherapy.
Samuel C Augustine, David M Colcher, Frank J Rutar, Jeffrey P Norenberg, Kao Vang

J Am Pharm Assoc (2003)· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.
Samuel C Augustine, Jeffrey P Norenberg, David M Colcher, Julie M Vose, Lisa S Gobar

J Am Pharm Assoc (Wash)· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis